Cargando…
Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro
BACKGROUND: Inflammation is a key contributor to central nervous system (CNS) injury such as stroke, and is a major target for therapeutic intervention. Effective treatments for CNS injuries are limited and applicable to only a minority of patients. Stem cell-based therapies are increasingly conside...
Autores principales: | Redondo-Castro, Elena, Cunningham, Catriona, Miller, Jonjo, Martuscelli, Licia, Aoulad-Ali, Sarah, Rothwell, Nancy J., Kielty, Cay M., Allan, Stuart M., Pinteaux, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393041/ https://www.ncbi.nlm.nih.gov/pubmed/28412968 http://dx.doi.org/10.1186/s13287-017-0531-4 |
Ejemplares similares
-
Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming
por: Redondo-Castro, Elena, et al.
Publicado: (2018) -
Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke
por: Cunningham, Catriona J., et al.
Publicado: (2020) -
Adhesion to the extracellular matrix is required for interleukin-1 beta actions leading to reactive phenotype in rat astrocytes
por: Summers, Lauren, et al.
Publicado: (2010) -
Characterization of a conditional interleukin‐1 receptor 1 mouse mutant using the Cre/LoxP system
por: Abdulaal, Wesam H., et al.
Publicado: (2016) -
Therapeutic potential of extracellular vesicles in preclinical stroke models: a systematic review and meta-analysis
por: Thomas, Josephine M, et al.
Publicado: (2020)